10.7 Inspection Methods, Self-Audits & Continuous Readiness
Key Takeaways
Sterile compounding programs face several kinds of inspection: internal self-audits, state board inspections (often with required self-inspection forms), FDA inspections (for cause at 503A pharmacies, routine and risk-based at 503B facilities), and accreditation surveys such as The Joint Commission's.
Inspectors combine document review, direct observation of garbing and aseptic technique, staff interviews, facility walk-throughs and tracers that follow a CSP from order to administration.
The Joint Commission's tracer method follows real patients and processes across departments to test whether practice matches policy, rather than reviewing documents alone.
Continuous readiness means current SOPs, complete and retrievable records, excursions investigated and closed, and staff who can explain their tasks, so any day could be inspection day.
After an inspection, findings go into CAPA with effectiveness checks. For FDA Form 483 observations, FDA considers responses received within 15 business days.
10.7 Inspection Methods, Self-Audits & Continuous Readiness
Sterile compounding is inspected more often than most pharmacy work, and the BCSCP outline expects you to know how those inspections are done (task 3A5). It also expects you to run a program that is ready at any time, which the outline calls continuous readiness under quality management (3A3).
Who inspects
| Inspector | Scope and typical trigger | Notes |
|---|---|---|
| Internal auditors (designated person, quality staff, peers) | Scheduled self-audits; after changes or excursions | The most useful inspections, because you choose the depth |
| State board of pharmacy | Routine licensure inspections, complaints, new or changed permits | Many boards require annual self-inspection forms; Washington's, for example, has USP <797> and <800> addenda |
| FDA | 503A: usually for cause (adverse events, complaints, state referral). 503B: risk-based surveillance inspections | Findings are recorded on Form FDA 483 and may lead to a Warning Letter |
| CMS and state survey agencies | Hospital Conditions of Participation, including pharmaceutical services and infection control | Deficiencies can put Medicare participation at risk |
| Accreditors | The Joint Commission (including its optional Medication Compounding Certification), ACHC/PCAB for compounding pharmacies | Survey against their own standards, which build in USP <797> and <800> |
| NABP inspection programs | Inspections that some state boards accept for nonresident (out-of-state) pharmacies | Useful for pharmacies that ship across state lines |
Inspection methods
- Document review: SOPs and their review dates, training and competency files, certification reports, monitoring results and trends, cleaning logs, temperature and pressure logs, MFRs and CRs, investigations and CAPA, complaints and recalls.
- Direct observation: watching hand hygiene, garbing order, glove disinfection, first-air discipline, cleaning technique and material transfer. Inspectors compare what they see with the SOP.
- Interviews: asking a technician, "What do you do if the pressure alarm sounds?" or "Where is the spill kit, and when do you use a respirator?" Staff should answer from the SOP, not guess.
- Environmental walk-through: leaks, damaged surfaces, cardboard, clutter, equipment placement, sink and drain locations, signs and access control for HD areas.
- Tracers: following an actual CSP or patient through the system, from order, verification, compounding and labeling to storage, delivery, administration and monitoring. The Joint Commission's tracer method tests whether departments' processes connect and match their policies.
- Data review: trends, repeat excursions and repeat competency failures that point to system weakness.
Running a self-audit or gap analysis
- Build the checklist from the standard. State self-inspection forms, such as Washington's USP <797> addendum, which quotes the chapter section by section, are good starting templates. Add USP <800>, your state's rules and your accreditor's standards.
- Score each requirement: compliant, not compliant, or not applicable, with evidence (the document, what was observed, who was interviewed).
- Rank gaps by risk: patient harm first (sterility, dosing), then worker safety (HD containment), then documentation.
- Assign a CAPA to each gap, with an owner, a due date and an effectiveness check.
- Repeat at least annually, and after renovations, new equipment, new CSP categories or major excursions.
Mock tracers, where a colleague follows a CSP from start to finish, show handoff gaps that checklists miss.
Continuous readiness
Being ready every day means the following:
- Records are complete and retrievable. USP <797> requires records to be readily retrievable. Monitoring results, certifications and training files should be found in minutes.
- SOPs are current. Every SOP has been reviewed within 12 months, and practice matches the current version.
- No open-ended excursions. Every out-of-range result has a documented investigation, corrective action and effectiveness check.
- Competencies are on schedule. No compounder is working past a garbing or media-fill due date.
- The environment is inspection-ready: no cardboard, no clutter, no damaged surfaces, and cleaning logs up to date.
- Staff can explain their tasks, the reason for them, and what to do when something goes wrong.
During and after an inspection
- Escort the inspectors, provide requested records promptly, answer factually, and never guess or volunteer speculation. Keep notes of what was asked and seen.
- Fix simple findings on the spot where you can, and document that you did. An immediate fix does not remove the observation.
- At the closing conference, make sure you understand each observation.
- Respond in writing. For an FDA Form 483, FDA considers a response received within 15 business days before deciding on further action. State boards set their own deadlines.
- Put every finding into CAPA, with root cause, corrective and preventive actions, and objective proof that they worked (see 12.1).
Preparing staff for inspector questions
Inspectors often ask front-line staff instead of managers. Common questions include:
- "Show me how you garb."
- "How often is the sporicidal applied, and where is that documented?"
- "What would you do if the pressure monitor alarmed during compounding?"
- "Where is the spill kit, and when do you wear a respirator?"
- "How do you know this BUD is right?"
Short practice rounds, where a peer asks the same questions, build confidence and expose gaps between the SOPs and actual practice. Keep a current document index so anyone can quickly find the SOP list, the last two certification reports, monitoring trends, competency status and open CAPAs.
During an accreditation survey, a surveyor picks a patient receiving a compounded PN and follows it from order entry through pharmacist verification, compounding, labeling, delivery, nursing administration and laboratory monitoring, interviewing staff at each step. What is this method called?
A gap analysis
A certification
A media-fill simulation
A tracer
Which practice best shows continuous inspection readiness in a sterile compounding program?
Updating SOPs and backfilling logs in the weeks before an expected state inspection
Letting only the designated person talk to inspectors, while other staff are told not to answer questions
Keeping monitoring results in personal email folders
Scheduled internal audits and mock tracers, SOPs reviewed within 12 months, same-day documentation, and every excursion closed with a documented investigation and effectiveness check
An inspector wants to know whether garbing practice really matches the facility's SOP. Which inspection method gives the strongest evidence?
Reading the garbing SOP
Reviewing the training attendance roster
Directly observing staff hand hygiene and garbing and comparing each step with the SOP, then checking recent GFT results
Asking the pharmacy director whether staff follow the SOP
Sections you finish are checked off in the contents.